Results 281 to 290 of about 499,895 (395)

Extrachromosomal Circular DNA: Emerging Insights Into Cardiovascular Disease Mechanisms and Biomarker Potential

iLABMED, EarlyView.
Extrachromosomal circular DNA (eccDNA) has quite recently turned out to be a cardinal component in cardiovascular diseases (CVD), governing the gene expression and mechanisms of disease causation. Studies indicated an upregulation of eccDNA in pulmonary arterial hypertension (PAH), which makes it strikingly potential as a sensitive and specific ...
Saim Mahmood Khan, Jawairya Muhammad Hussain, Surraiya Riaz Mahmood Khan, Bushra Nadeem, Tahniyat Naseem, Hammad Jawed, Aina Lashari   +6 more
wiley   +1 more source

Four-dimensional flow magnetic resonance assessment of alcohol septal ablation for hypertrophic obstructive cardiomyopathy and surgical valve replacement for aortic valve stenosis. [PDF]

Front Cardiovasc Med
Aoyama R, Okino S, Fukuzawa S.
europepmc   +1 more source

The short-term effect of cibenzoline on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy as compared with bisoprolol Isao Kondo, Katsufumi Mizushige, Shiro Nozaki, Yasuyoshi Iwado, Masakazu Kohno. The Second Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan

, 2001

openalex   +1 more source

Mitochondrial dysfunction: Related diseases, influencing factors, and detection

Interdisciplinary Medicine, EarlyView.
Mitochondrial dysfunction is implicated in the pathogenesis of numerous diseases, including neurological disorders, cancers, and cardiovascular conditions, through mechanisms such as mitochondrial DNA mutations, dysregulation of mitochondrial network dynamics, and impaired mitophagy.
Zhaojin Li, Shiyu Li, Wanying Chen, Ziyu Zhang, Chun Pan, Peng Lei, Cheng Cheng, Junyou Zhu, Hanxiao Sun, Zhenning Dai   +9 more
wiley   +1 more source

Severe cibenzoline toxicity in hypertrophic obstructive cardiomyopathy successfully managed with extracorporeal membrane oxygenation and percutaneous transluminal septal myocardial ablation - A case report. [PDF]

J Cardiol Cases
Yagasaki H, Suzuki T, Watanabe K, Warita S, Iwama M, Noda T.   +5 more
europepmc   +1 more source

Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy [PDF]

, 2016
Borgeat, K A, Brodbelt, D C, Connolly, D J, Fuentes, V L, Payne, J R   +4 more
core   +1 more source

Catheter interventional septal abiation for hypertrophic obstructive cardiomyopathy: an analysis of the follow-up data from the registry of the german society of cardiology

, 2002
Lothar Faber, Hubert Seggewiß, H. Kuhn, Frank Gietzen, Peter Boekstegers, L Seipel, U. Gleichmann, Dieter Horstkotte   +7 more
openalex   +1 more source

New insights into applications of base editor in hereditary disorders

Interdisciplinary Medicine, EarlyView.
Abstract Hereditary disorders are a group of diseases caused by genetic mutations or chromosomal variations. Although the incidence of each genetic disorder is relatively low, patients affected by the disease generally experience a range of severe symptoms, including blindness, disability, and even premature death. In addition, the available treatments
Maoping Cai, Linhui Zhang, Liqing Li, Yue Liu, Canbin Lv, Yan Shi, Jianyuan Zhao, Dingwei Ye, Yuanyuan Qu   +8 more
wiley   +1 more source

Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy. [PDF]

J Am Heart Assoc
Patel N, Shetty NS, Gaonkar M, Shahid A, Divekar GP, Pampana A, Vekariya N, Li P, Ahmed MI, Arora G, Arora P.   +10 more
europepmc   +1 more source

The long-term follow-up results of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor experience (1996–2001)

, 2002
Valerian Fernandes, Sherif F. Nagueh, Nasser Lakkis, Jennifer Franklin, Robert Roberts, William H. Spencer   +5 more
openalex   +1 more source